A comparative study of two structurally related analogs of Asp1-Ile5-angiotensin II.
D000311:Adrenal Glands / Q000502:physiology; D000315:Adrenalectomy; D000626:Aminopeptidases / Q000494:pharmacology; D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D001011:Aorta / Q000187:drug effects; D001224:Aspartic Acid / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D003106:Colon / Q000187:drug effects; D010450:Endopeptidases / Q000097:blood; D005769:Gastrointestinal Motility / Q000187:drug effects; D006207:Half-Life; D006321:Heart / Q000187:drug effects; D066298:In Vitro Techniques; D007532:Isoleucine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D010477:Perfusion; D011817:Rabbits; D051381:Rats; D012521:Sarcosine / Q000494:pharmacology; D014633:Valine / Q000494:pharmacology
D007532:Isoleucine; D000804:Angiotensin II; D001224:Aspartic Acid; D010450:Endopeptidases; D000626:Aminopeptidases; D014633:Valine; D012521:Sarcosine